CHENGDU, China, Aug. 6 /PRNewswire-Asia/ -- China SHESAYS Medical Cosmetology Inc. (OTC Bulletin Board: CSAY) (the "Company" or "SHESAYS"), a leading Chinese medical cosmetology service provider, becomes the first and also the only one US listed Chinese company in cosmetology industry through a reverse merger transaction dated June 7, 2010.
Substantially all of the Company’s operations are now conducted through its indirectly wholly-owned operating subsidiaries in China, namely Sichuan SHESAYS Cosmetology Hospital Co., ltd. On June 7, 2010, through a share issuance and share purchase, Sichuan SHESAYS Cosmetology Hospital Co., ltd. acquired 95% of the shell company SN Strategies Corp. and merged into the shell company.
On July 23, 2010, the combined company SN Strategies Corp. changed its name to China SHESAYS Medical Cosmetology Inc. In connection with the name change, the Company received a new CUSIP and a new ticker symbol from FINRA. The ticker symbol was changed from SNGI to CSAY.
"We are very excited to have completed our merger transaction towards US capital market," said Mr. Yixiang Zhang, Chairman of the Board and Chief Executive Officer of China SHESAYS Medical Cosmetology Inc. "As a leading cosmetology hospital chain in China, we are well positioned in the medical cosmetology industry, one of the fastest growing industries in China. I believe we can realize our expansion strategy of opening chain cosmetology hospitals and clinics as well as potential mergers and acquisitions of similar hospitals in China with the support from US capital market."
About China SHESAYS Medical Cosmetology Inc.
Founded in 2005, China SHESAYS Medical Cosmetology Inc. provides medical cosmetology service in China. Over the past five years, SHESAYS has become one of the fastest growing cosmetology hospitals in China and the most well-known cosmetology hospital chain in Sichuan province, P.R. China. SHESAYS now ranks top five in the medical cosmetology industry in China. With the support of the public capital markets and access to capital, the Company believes that it will execute its expansion strategy to open chain hospitals and clinics as well as potential merger and acquisition in China, which will result in improved long-term growth and increased market share
About Mr. Yixiang Zhang
Yixiang Zhang, Chairman of the Board & CEO, graduated from Huaxi Medical School of Sichuan University with a bachelor’s degree majoring in public health and is a member of Chengdu Youth Federation and tutor of Youth Business China (YBC). Mr. Zhang has ten years’ working experience in the field of pharmaceutics and medical care. Mr. Zhang is also an expert in enterprise chain operation and brand management. From 1998 to 2000, Mr. Zhang was the sales manager and investment manager of the chain drugstores in 999 Group, the leading enterprise in the field of pharmaceutics in China. In 2001, Mr. Zhang established his own pharmaceutical and medical devices company. In 2005, he established Sichuan SHESAYS Cosmetology Hospital Co., ltd. and has been the CEO and chairman of the board since then.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, completion of definitive agreements with local and provincial governments, wind farms and utility companies, number of wind turbine systems ordered, manufactured, delivered and installed, the Company’s future strategic plans, the outlook for the Company’s markets and the demand for its products, estimated sales, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
